2025 Implantable Infusion Pumps Market Outlook: Key Indicators Shaping Growth Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Implantable Infusion Pumps Industry Market Size Be by 2025?
The market size for implantable infusion pumps has witnessed consistent growth over the past few years. The market is projected to expand from $19.59 billion in 2024 to $20.48 billion in 2025, with a compound annual growth rate (CAGR) of 4.6%. The past period's market growth can be linked to factors such as chronic disease management, an increase in the aging population, pain management, and obtaining regulatory approvals.

What's the Long-Term Growth Forecast for the Implantable Infusion Pumps Market Size Through 2029?
The market for implantable infusion pumps is projected to witness significant expansion in the coming years, reaching a value of $26.89 billion in 2029, with a compound annual growth rate (CAGR) of 7.0%. This surge during the forecasted period can be attributed to factors such as personalized medicine, remote patient monitoring, advancements in drug development, and management of chronic diseases. Leading trends during this period are expected to include the adoption of minimally invasive implantation procedures, remote monitoring and programming, intrathecal pain management, and interdisciplinary collaboration.

View the full report here:
https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report

What Are the Key Growth Drivers Fueling the Implantable Infusion Pumps Market Expansion?
The growth in the number of individuals suffering from chronic pain, cancer, and diabetes is anticipated to propel the need for implantable infusion pumps which are widely used in administering medicinal drugs for the treatment of these diseases. The aging population and changes in societal behavior are contributing to a surge in chronic illnesses and disorders across the globe. In conditions like chronic arachnoiditis, where one of the membranes around the spinal cord inflames, implantable infusion pumps are efficacious in delivering smaller doses of drugs that offer improved pain management. For instance, a report by the American Cancer Society, a health organization based in the United States, revealed in January 2022 that 609,360 cancer-related deaths and 1.9 million new cancer cases are projected for 2022 in the US. It is also predicted that there will be 10,470 cases of pediatric cancer and 5,480 adolescent cancer diagnoses in 2022. Consequently, the escalating occurrence of chronic diseases is likely to stimulate the expansion of the implantable infusion pumps market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3347&type=smp

What Are the Key Trends Driving Implantable Infusion Pumps Market Growth?
There is a growing trend among businesses operating in the implantable infusion pump market to develop intelligent infusion pumps. The incorporation of wireless technology into health monitoring devices is on the rise, making them more user-friendly, interconnected, and capable of detailed data analysis. With the application of wireless technology, data can be transferred from the device to a smartphone or other wireless device via Bluetooth or a cellular connection. This data is then processed and displayed, creating results that can be used for detailed analysis and individual health condition checks. Development of software platforms for patient monitoring is also underway; these platforms will help minimize human error.

How Is the Implantable Infusion Pumps Market Segmented?
The implantable infusion pumps market covered in this report is segmented -

1) By Type: Patient-Controlled Analgesia (PCA) Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Syringe Pumps, Other Types
2) By Applications: Oncology, Pediatrics Or Neonatology, Gastroenterology, Hematology, Diabetes, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics

Subsegments:
1) By Patient-Controlled Analgesia (PCA) Pumps: Morphine PCA Pumps, Fentanyl PCA Pumps, Other Opioid PCA Pumps
2) By Enteral Pumps: Tube Feeding Pumps, Syringe-based Enteral Pumps, Continuous Or Intermittent Feeding Pumps
3) By Insulin Pumps: Insulin Delivery Pumps, Insulin Patch Pumps, Smart Insulin Pumps
4) By Elastomeric Pumps: Disposable Elastomeric Pumps, Reusable Elastomeric Pumps
5) By Syringe Pumps: Small Volume Syringe Pumps, Large Volume Syringe Pumps
6) By Other Types: Chemotherapy Infusion Pumps, Antibiotic Infusion Pumps, Pain Management Pumps

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3347&type=smp

Which Companies Are Leading the Charge in Implantable Infusion Pumps Market Innovation?
Major companies operating in the implantable infusion pumps market include Medtronic plc, Boston Scientific Corporation, Nevro Corp, LivaNova PLC, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical a Smiths Group company, Terumo Corporation, Johnson & Johnson, Greatbatch Medical, NeuroPace Inc., Primetech Corporation, Flowonix Medical Inc., F. Hoffmann-La Roche Ltd, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Micrel Medical, Insulet Corporation, ICU Medical Inc., Becton Dickinson and Company (BD), Roche Diagnostics International AG, Abbott Laboratories, Hospira, Stryker Corporation, Zimmer Biomet Holdings Inc., Teleflex Incorporated, C. R. Bard Inc., AngioDynamics Inc., Merit Medical Systems Inc., NIPRO Medical Corporation, IRadimed Corporation, Zyno Medical, Tricumed Medizintechnik GmbH, Q Core Medical Ltd., Ivenix Inc., Tandem Diabetes Care Inc.

Which Regions Are Leading the Global Implantable Infusion Pumps Market in Revenue?
North America was the largest region in the implantable infusion pumps market in 2023. Asia-Pacific was the second-largest region in the implantable infusion pumps market. The regions covered in the implantable infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3347

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.